FibroBiologics, a clinical-stage biotech company, closed a private placement raising approximately $0.5 million by selling 298,508 shares and warrants to its Chief Scientific Officer, Dr. Hamid Khoja. The shares and warrants were priced at $1.675 each, matching the market price. This investment highlights confidence in FibroBiologics' advancing clinical programs, including treatments for wound care, psoriasis, and orthopedics. The company plans to use the proceeds for general corporate purposes and working capital as it continues developing its fibroblast-based therapies.
FibroBiologics' recent private placement is presented alongside Pluang's health sector data for context. As of Sep 17, 2026 18:11 WIB, out of 91 priced US health stocks on Pluang, 63 rose and 25 fell. Notably, FLNA rose 6.69% to USD 0.73 with a typical hold time of 39 days, while MRNA increased 4.38% to USD 152.00 and ASND declined 3.31% to USD 239.50, with Pluang order activity showing contrasting buy-sell splits among these names.
FREELANDER participated in the 2026 Chery International User Summit in Wuhu, China, showcasing the international variant of its FREELANDER 8 model through a day-and-night program on October 19. The day featured the first international test drive on c...
Tesla's Q3 earnings will be closely watched as deliveries beat forecasts but profitability remains uncertain due to potential pricing concessions and rising costs. Meta's shares have rallied 37% thanks to its AI product Muse, though high spending rai...
Disc Medicine announced a webcast on October 19, 2026, to discuss topline results from its APOLLO Phase 3 trial of bitopertin, an investigational oral drug for erythropoietic protoporphyria (EPP). Bitopertin targets glycine transporter 1 to modulate ...
Ethena (ENA) saw a notable price increase of 9.15% over four hours, reaching $0.1921 on the Binance spot ENA/USDT pair as of October 18. Despite a smaller 24-hour gain of 2.07%, the short-term surge highlights increased trading activity. During the s...
An unidentified large trader's short position on Ether (ETH) valued at $26.64 million faced partial liquidation after the ETH price rebounded to $2,409. The short was initially opened at $2,366 involving 13,830 ETH worth $32.72 million. During the pr...
